Dermatological picosecond laser treatment systems and methods using optical parametric oscillator
Dermatological systems and methods for providing picosecond laser pulses at a plurality of treatment wavelengths, wherein at least one of the wavelengths is provided by an optical parametric oscillator (OPO) capable of providing picosecond laser pulses at a wavelength for treating one or more target tissue types such as a sebaceous gland, sebum, or collagen. In some embodiments, multiple OPOs may be provided to enable a wide range of selectable treatment wavelengths.
1. A dermatological treatment system for treating a plurality of skin conditions using pulsed laser light having a selected wavelength, comprising:
a laser engine adapted to output pulsed laser light having a first wavelength of from 500-1200 nm, a pulse width of 10 psec to 10 nsec, and a first pulse energy of from 100 mJ/pulse to 5 J/pulse; and
at least one optical parametric oscillator (OPO) adapted to receive pulsed laser light from the laser engine and to generate OPO output pulses having a second wavelength selected from a wavelength at which sebum tissue has a higher absorption coefficient than water and a wavelength at which collagen tissue has a higher absorption coefficient than water, wherein the OPO output pulses comprise one of OPO signal pulses and OPO idler pulses; and
an applicator adapted to receive and apply a selected one of the pulsed laser light output from the laser engine and the OPO output pulses to a target body tissue comprising sebum tissue, collagen tissue, and a third tissue that is neither sebum nor collagen.
2. The dermatological treatment system of claim 1 , wherein the laser engine is adapted to operate in one of a first treatment mode and a second treatment mode,
wherein in the first treatment mode the laser engine outputs laser pulses at a pulse frequency of from 0.1 Hz to 100 Hz; and
wherein in the second treatment mode the laser engine outputs laser bursts at a burst frequency of 1 Hz to 100 Hz, each laser burst having a burst duration of from 500 μsec to 50 msec, a burst energy of from 10 mJ to 20 J, and comprising a plurality of laser pulses having a pulse frequency greater than 100 Hz;
the system further comprising
a laser engine controller for controlling the operation of the laser engine in the first treatment mode and the second treatment mode.
3. The dermatological treatment system of claim 2 , further comprising a user interface coupled to the laser engine controller, wherein the user interface allows a user to select one of the first treatment mode and the second treatment mode, and to control at least one of the pulse frequency and the burst frequency.
4. The dermatological treatment system of claim 1 , wherein the at least one OPO comprises:
a first OPO adapted to receive pulsed laser light from the laser engine and to generate OPO output pulses having a second wavelength at which sebum tissue has a higher absorption coefficient than water, and
a second OPO adapted to receive pulsed laser light from the laser engine and to generate OPO output pulses having a third wavelength at which collagen tissue has a higher absorption coefficient than water.
5. The dermatological system of claim 4 , further comprising
a third OPO adapted to receive pulsed laser light from the laser engine and to generate OPO output pulses having a fourth wavelength that is a wavelength at which water has a higher absorption coefficient than sebum tissue and collagen tissue.
6. The dermatological system of claim 5 , further comprising
an OPO selector allowing a user to select one of the first OPO, the second OPO, and the third OPO to receive pulsed laser light from the laser engine.
7. The dermatological system of claim 5 , wherein
the second wavelength is a wavelength within one of a first range of from 1700-1770 nm and a second range of from 2280-2360 nm;
the third wavelength is a wavelength within a third range of 5900-9500 nm
the fourth wavelength is a wavelength within one of a fourth range of from 1400-1850 nm, a fifth range of from 1910-1950 nm, and a sixth range of from 2600-3500 nm.
8. The dermatological system of claim 7 , wherein the second wavelength is one of about 1726 nm and about 2300 nm, and wherein the third wavelength is one of about 6049 nm and about 6476 nm.
9. The dermatological treatment system of claim 1 , wherein the first wavelength is a wavelength within the range of from 1000-1200 nm, the system further comprising:
a second harmonic generator (SHG) adapted to receive the pulsed laser light output from the laser engine and to output pulsed laser light having an SHG output wavelength that is half the first wavelength; and
an OPO input selector allowing a user to select one of the pulsed laser light output from the laser engine and the pulsed laser light output from the SHG as the input to the OPO.
10. The dermatological treatment system of claim 9 , wherein the OPO input selector comprises at least one optical multiplexer adapted to direct the pulsed laser light output from the laser engine to a selected one of the at least one OPO and the SHG, wherein the user can select an OPO input wavelength by directing laser pulses from one of the laser engine and the SHG as the input to the at least one OPO.
11. The dermatological treatment system of claim 9 , further comprising:
a user-selectable first output path located between the laser engine and the SHG, wherein the user may select the first output path to output first laser pulses to the applicator;
a user-selectable second output path located between the SHG and the OPO, wherein the user may select the second output path to output second harmonic laser pulses to the applicator; and
a user-selectable third output path located proximate the OPO signal output, wherein the user may select the third output path to output OPO signal pulses to the applicator.
12. The dermatological treatment system of claim 1 , further comprising an applicator input selector comprising at least one optical multiplexer allowing a user to direct a selected one of pulsed laser light output from the laser engine and OPO output pulses to the applicator for application to the target body tissue of the patient.
13. The dermatological treatment system of claim 1 , wherein the laser engine comprises one of:
a) a laser engine comprising:
a laser diode adapted to output pulsed laser light having a selected wavelength;
a microlaser adapted to receive the pulsed laser light output from the laser diode and to output pulsed laser light having the first wavelength, the first pulse width, and a microlaser pulse energy of from of from 10 μJ/pulse to 5 mJ/pulse; and
an amplifier adapted to receive the pulsed laser light output from the microlaser and to output amplified laser pulses having the first wavelength, the first pulse width, and the first pulse energy; and
b) a hybrid modelocked laser.
14. The dermatological treatment system of claim 1 , wherein each of the at least one OPOs comprises:
a resonant cavity including a nonlinear crystal comprising one of beta barium borate (BBO), lithium niobate (LiNbO3), potassium titanyle arsenate (KTA), potassium titanium oxide phosphate (KTP) and zinc germanium phosphide (ZGP);
a first mirror coupled to a first end of the resonant cavity;
a second mirror coupled to a second end of the resonant cavity; and
an adjustment element operable by a user to adjust the second wavelength of the OPO output pulses.
15. The dermatological treatment system of claim 1 , further comprising an adjustment element operable by a user to adjust the second wavelength of the OPO output pulses, wherein the adjustment element comprises at least one of:
a crystal angle positioner coupled to the nonlinear crystal, wherein the crystal angle positioner is capable of varying the angle of incidence of the nonlinear crystal to the beam axis of the OPO input pulses to adjust the second wavelength; and
a temperature selector stabilizer to adjust the temperature of the nonlinear crystal to a desired temperature.
16. The dermatological treatment system of claim 1 , wherein the applicator comprises a handpiece constructed and arranged to be held in the hand of a user.
17. The dermatological treatment system of claim 1 , the system further comprising a housing within which the laser engine is located, wherein one of the at least one OPOs is located in one of the applicator and the housing.
18. The dermatological treatment system of claim 17 , further comprising
an articulated arm having a proximal end coupled to the housing and a distal end coupled to the applicator, wherein a user may select one of pulsed laser light output from the laser engine and OPO output pulses to be applied to the target tissue through an optical medium located in the articulated arm.
19. The dermatological treatment system of claim 1 , wherein the laser engine comprises
a laser diode adapted to output pulsed laser light having a selected laser diode wavelength;
a microlaser adapted to output pulsed laser light at the first wavelength, the microlaser comprising:
an input coupler comprising a mirror having a high transmission at the selected laser diode wavelength and a high reflectance at the first wavelength;
a nonlinear Nd:YAG crystal having a length of 2-10 mm;
a saturable absorber comprising a Cr 4+ :YAG crystal with an unsaturated transmission between 5 and 40%, wherein the saturable absorber is monolithically bonded to the nonlinear Nd:YAG crystal; and
an output coupler having a transmission of the first wavelength of from about 25% to about 75%; and
a multi-stage amplifier comprising a Nd:YAG crystal to amplify the pulsed laser light output from the microlaser.
20. An optical parametric oscillator (OPO) system for use in a dermatological laser treatment system, the OPO system comprising:
an input coupler for receiving laser input pulses having a pulse width of from 10 psec to 100 nsec and a first wavelength, the input coupler comprising a mirror having a high transmission (HT) at the first wavelength and a high reflectance (HR) at one of an OPO signal wavelength and an OPO idler wavelength;
a resonant cavity including a nonlinear crystal having a crystal length between 5 and 40 mm, wherein the resonant cavity produces OPO output pulses in response to receiving the laser input pulses, the OPO output pulses having a second wavelength selected from a wavelength at which sebum tissue has a higher absorption coefficient than water and a wavelength at which collagen tissue has a higher absorption coefficient than water, wherein the OPO output pulses comprise one of OPO signal pulses and OPO idler pulses; and
an output coupler comprising a mirror having a high reflectance (HR) at the first wavelength and transmitting a selected portion of the second wavelength.
21. The OPO system of claim 20 , wherein the nonlinear crystal comprises one of beta barium borate (BBO), lithium niobate (LiNbO3), potassium titanyle arsenate (KTA), potassium titanium oxide phosphate (KTP) and zinc germanium phosphide (ZGP).
22. The OPO system of claim 20 , wherein the second wavelength the second wavelength is a wavelength within one of a first range of from 1700-1770 nm, a second range of from 2280-2360 nm, and a third range of 5900-9500 nm.
23. The OPO system of claim 20 , wherein the second wavelength is selected from one of about 1726 nm, about 2305 nm, about 6049 nm, and about 6476 nm.
24. The OPO system of claim 20 , further comprising an adjustment element operable by a user to adjust the second wavelength of the OPO output pulses, wherein the adjustment element comprises at least one of:
a crystal angle positioner coupled to the nonlinear crystal, wherein the crystal angle positioner is capable of varying the angle of incidence of the nonlinear crystal to the beam axis of the OPO input pulses to adjust the second wavelength; and
a temperature selector stabilizer to adjust the temperature of the nonlinear crystal to a desired temperature.
25. The OPO system of claim 20 , wherein the OPO output pulses comprise OPO signal pulses, and the OPO signal pulses have a wavelength selected to correspond to an OPO idler wavelength for which a portion of the energy of the idler pulses is at least partially absorbed by the nonlinear crystal.